See the Difference

FDA approved, superior breast tomosynthesis cancer screening technology1,2*
A Genius 3D MAMMOGRAPHY™ exam delivers a series of high-resolution images of different layers of the breast. This technology provides screening accuracy unmatched by traditional 2D digital mammography.1

Benefits of Genius 3D MAMMOGRAPHY™ exams
The Selenia® Dimensions® system, with its advanced software capabilities, can generate both digital breast tomosynthesis images and a composite digital 2D image, all from one breast compression.3-5

Learn More About Genius 3D MAMMOGRAPHY

Clinically proven results
Numerous clinical studies have demonstrated that with a Genius 3D MAMMOGRAPHY™ exam, Radiologists are able to more accurately screen, triage to biopsy, or dismiss a potential false positive—regardless of a woman's age or breast density.6,7 Proven in both research and clinical use.

  • Over 750,000 patients evaluated in clinical studies
  • Over 100 peer-reviewed publications
  • Over 2,400 systems in all 50 states
  • Over 10 million women screened in the US since 2011

Benefit for patients, providers, and institutions
For patients
A Genius 3D MAMMOGRAPHY™ exam allows you to offer women in your community a more accurate, clinically proven breast cancer screening technology.1

  • 41% better detection of invasive breast cancers1
    - Proven to help detect cancer 15 months earlier
  • A 40% initial reduction in callbacks, and as much as 47% over 3 years1,2,8
    - This may mean being spared the emotional, practical, and economic burdens of additional diagnostic evaluations, including biopsies
  • Benefits women of all ages and breast densities6,7
    - Proven to reduce recalls for women with dense breasts by 14%
For providers
Offering your patients a clinically proven, more accurate mammogram means giving them a chance at earlier invasive breast cancer detection.1* This is important, because when breast cancer is found early, more treatment options are available.

For institutions
A Genius 3D MAMMOGRAPHY™ exam can help draw women—often the gatekeepers for family healthcare—to your facility, by offering leading-edge, clinically proven breast cancer screening technology.*

Learn more

Contact a Genius Rep

Hologic® on Facebook Hologic® on Twitter Hologic® on LinkedIn

*Versus 2D mammography alone. Genius™ 3D MAMMOGRAPHY™ exams are available only on the Hologic Selenia® Dimensions® system.
1. Friedewald S, Rafferty E, Rose S, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311(24):2499-2507.
2. Rose S, Tidwell A, Bujnock L, Kushwaha A, Nordmann A, Sexton R Jr. Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR Am J Roentgenol. 2013;200(6):1401-1408.
3. Skaane P, Bandos A, Eben E, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014;271(3):655-663.
4. Zuley M, Guo B, Catullo V, et al. Comparison of two-dimensional synthesized mammograms versus original digital mammograms alone and in combination with tomosynthesis images. Radiology. 2014;271(3):664-671.
5. FDA PMA submission P080003/S001 physician labeling.
6. Skaane P, Bandos A, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267(1):47-56.
7. Rafferty E, Smith A, Niklason L. FFDM versus FFDM with tomosynthesis for women with radiologically dense breasts: an enriched retrospective reader study. Paper presented at: Annual Radiological Society of North America (RSNA) Meeting; November 2011; Chicago, IL.
8. JAMA Oncology, Published online February 18, 2016. doi:10.1001/jamaoncol.2015.5536Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography Outcomes Analysis from 3 Years of Breast Cancer Screening

EMB-00838 Hologic, 3D MAMMOGRAPHY, Dimensions, Genius, Selenia and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries. This information is intended for medical professional in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative or write to